The Evolution of Care of Cancers of the Head and Neck Region: State of the Science in 2020
Authors:
- Flora YanFYFlora Yan
- Hannah M. KnochelmannHKHannah M. Knochelmann
- Patrick F. MorganPMPatrick F. Morgan
- John M. KaczmarJKJohn M. Kaczmar
- David M. NeskeyDNDavid M. Neskey
- Evan M. GraboyesEGEvan M. Graboyes
- Shaun A. NguyenSNShaun A. Nguyen
- Besim OgretmenBOBesim Ogretmen
- Anand K. SharmaASAnand K. Sharma
- Terry A. DayTerry A. Day
Open Access
Abstract
Cancers that arise in the head and neck region are comprised of a heterogeneous group of malignancies that include carcinogen- and human papillomavirus (HPV)-driven mucosal squamous cell carcinoma as well as skin cancers such as cutaneous squamous cell carcinoma, basal cell carcinoma, melanoma, and Merkel cell carcinoma. These malignancies develop in critical areas for eating, talking, and breathing and are associated with substantial morbidity and mortality despite advances in treatment. Understanding of advances in the management of these various cancers is important for all multidisciplinary providers who care for patients across the cancer care continuum. Additionally, the recent Coronavirus Disease 2019 (COVID-19) pandemic has necessitated adaptations to head and neck cancer care to accommodate the mitigation of COVID-19 risk and ensure timely treatment. This review explores advances in diagnostic criteria, prognostic factors, and management for subsites including head and neck squamous cell carcinoma and the various forms of skin cancer (basal cell carcinoma, cutaneous squamous cell carcinoma, Merkel cell carcinoma, and melanoma). Then, this review summarizes emerging developments in immunotherapy, radiation therapy, cancer survivorship, and the delivery of care during the COVID-19 era.Keywords
Funding Information
- National Institute of Dental and Craniofacial Research (DE016572, K08DE026542)
- National Cancer Institute (K08CA237858, CA243307)
- Doris Duke Charitable Foundation (DDCF2015209)
- National Institute of Mental Health (GM008716)
This publication has 146 references indexed in Scilit:
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged SkinJournal of Clinical Oncology, 2013
- Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant MetastasisJournal of Clinical Oncology, 2013
- Extranodal spread in the neck: MRI detection on the basis of pixel‐based time‐signal intensity curve analysisJournal of Magnetic Resonance Imaging, 2011
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- Multimodality Treatment of Merkel Cell Carcinoma: Case Series and Literature Review of 1024 CasesAnnals of Surgical Oncology, 2001
- The Nucleus Double-Array Cochlear Implant for Obliterated Cochleae2000
- An analysis of prognostic factors in cutaneous neuroendocrine carcinomaThe Laryngoscope, 1992
- Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphomaJournal of the American Academy of Dermatology, 1989